|
HIF1A expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.040600E-03 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.196060E-02 |
| Normal-vs-Stage2 |
5.351400E-01 |
| Normal-vs-Stage3 |
4.919200E-03 |
| Normal-vs-Stage4 |
1.562020E-02 |
| Stage1-vs-Stage2 |
2.380000E-01 |
| Stage1-vs-Stage3 |
3.640400E-01 |
| Stage1-vs-Stage4 |
3.318400E-01 |
| Stage2-vs-Stage3 |
1.030800E-01 |
| Stage2-vs-Stage4 |
1.116210E-01 |
| Stage3-vs-Stage4 |
8.041200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.429200E-04 |
| Normal-vs-AfricanAmerican |
3.233700E-02 |
| Normal-vs-Asian |
3.616000E-01 |
| Caucasian-vs-AfricanAmerican |
9.190400E-01 |
| Caucasian-vs-Asian |
1.288420E-02 |
| AfricanAmerican-vs-Asian |
1.518040E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.009160E-01 |
| Normal-vs-Female |
1.956310E-03 |
| Male-vs-Female |
2.045000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.044200E-03 |
| Normal-vs-Age(41-60Yrs) |
4.972200E-02 |
| Normal-vs-Age(61-80Yrs) |
6.352400E-02 |
| Normal-vs-Age(81-100Yrs) |
3.026600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.702200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.423600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.215600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.259000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.084800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.584600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.241800E-01 |
| Classical-VS-Follicular |
1.62436730732907E-12 |
| Classical-VS-Other |
8.101800E-02 |
| Classical-VS-Normal |
1.98970999999437E-05 |
| Tall-VS-Follicular |
1.05490000001929E-06 |
| Tall-VS-Other |
3.975900E-02 |
| Tall-VS-Normal |
8.809100E-04 |
| Follicular-VS-Other |
3.776600E-01 |
| Follicular-VS-Normal |
4.043000E-03 |
| Other-VS-Normal |
6.692400E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.113600E-01 |
| Normal-vs-N1 |
5.580100E-02 |
| N0-vs-N1 |
1.714850E-01 |
|
|
